Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lyons

Showing results (541-550 of 689) with videos related to

Pageof 69
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2024
A Randomized Phase 2 KINETIC Trial Evaluating SAGE-324/BIIB124 in Individuals with Essential TremorRodger J Elble, William G Ondo, Kelly E Lyons, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|September 14, 2025
Clarifying the so-called gull problem in the Gulf of Maine: Response to Taylor et al. (2024)Antony W Diamond, Linda Welch, Donald E Lyons, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2019
MDS evidence-based review of treatments for essential tremorJoaquim J Ferreira, Tiago A Mestre, Kelly E Lyons, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognitionTamson V Moore, Gretchen E Lyons, Natasha Brasic, et al.
American Heart Journal|January 28, 2010
Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failurePamela N Peterson, David J Magid, Ella E Lyons, et al.
Neurology|April 4, 2007
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson diseaseR Pahwa, M A Stacy, S A Factor, et al.
Ecological Applications : a Publication of the Ecological Society of America|February 22, 2023
Qualitative value of information provides a transparent and repeatable method for identifying critical uncertaintyMichelle L Stantial, Abigail J Lawson, Auriel M V Fournier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's diseaseRay L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Parasitology|September 10, 2005
Toxoplasma gondii dense granule protein 3 (GRA3) is a type I transmembrane protein that possesses a cytoplasmic dilysine (KKXX) endoplasmic reticulum (ER) retrieval motifF L Henriquez, M B Nickdel, R McLeod, et al.
Neurology|April 12, 2006
Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyR Pahwa, S A Factor, K E Lyons, et al.
Pageof 69

Showing results (541-550 of 689) with videos related to

Sort By:
Pageof 69
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2024
A Randomized Phase 2 KINETIC Trial Evaluating SAGE-324/BIIB124 in Individuals with Essential TremorRodger J Elble, William G Ondo, Kelly E Lyons, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|September 14, 2025
Clarifying the so-called gull problem in the Gulf of Maine: Response to Taylor et al. (2024)Antony W Diamond, Linda Welch, Donald E Lyons, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2019
MDS evidence-based review of treatments for essential tremorJoaquim J Ferreira, Tiago A Mestre, Kelly E Lyons, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognitionTamson V Moore, Gretchen E Lyons, Natasha Brasic, et al.
American Heart Journal|January 28, 2010
Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failurePamela N Peterson, David J Magid, Ella E Lyons, et al.
Neurology|April 4, 2007
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson diseaseR Pahwa, M A Stacy, S A Factor, et al.
Ecological Applications : a Publication of the Ecological Society of America|February 22, 2023
Qualitative value of information provides a transparent and repeatable method for identifying critical uncertaintyMichelle L Stantial, Abigail J Lawson, Auriel M V Fournier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's diseaseRay L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Parasitology|September 10, 2005
Toxoplasma gondii dense granule protein 3 (GRA3) is a type I transmembrane protein that possesses a cytoplasmic dilysine (KKXX) endoplasmic reticulum (ER) retrieval motifF L Henriquez, M B Nickdel, R McLeod, et al.
Neurology|April 12, 2006
Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyR Pahwa, S A Factor, K E Lyons, et al.
Pageof 69